Our data also supports that TMPRSS2 effect on modelling disease severity may be dependent on ACE2 levels, suggesting that the impact of this serine protease on COVID-19 might be better explored in combination to its partner ACE2. The gene discussed is TMPRSS2; the disease is COVID-19.